Shoulder Innovations Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Shoulder Innovations Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- SI
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001699350
Board of directors
-
Andrew Hykes · DirectorSince 2026
-
Casey M. Tansey · DirectorSince 2025
-
Geoffrey B. Pardo · DirectorSince 2025
-
Kevin K. Sidow · DirectorSince 2025
-
Matthew Fraser Ahearn · Director · Chief Operating OfficerSince 2025
-
Michael A. Carusi · DirectorSince 2025
-
Paul Buckman · DirectorSince 2025
-
Richard Buchholz · DirectorSince 2025
-
Robert Joseph Ball · Director · CEO & Executive ChairmanSince 2025
Chief executives
Robert Joseph Ball
· CEO & EXECUTIVE CHAIRMAN
Since July 2025
Board connections
3 of this board's directors also sit on 6 other boards.
- via Casey M. Tansey
- via Casey M. Tansey
- via Casey M. Tansey
- via Paul Buckman
- via Paul Buckman
- via Geoffrey B. Pardo
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $214,878
- 7 purchases by 3 insiders
- Sold, last 12 months
- $4,219,791
- 9 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Gilde Healthcare Holding B.V. 10% owner | Open-market sale | −2,095 | $22.60 | $47,347 |
| Aug 5, 2026 | Gilde Healthcare Holding B.V. 10% owner | Open-market sale | −7,338 | $22.64 | $166,132 |
| Aug 4, 2026 | Gilde Healthcare Holding B.V. 10% owner | Open-market sale | −99,812 | $22.77 | $2,272,719 |
| Aug 3, 2026 | Gilde Healthcare Holding B.V. 10% owner | Open-market sale | −10,751 | $22.71 | $244,155 |
| Jul 31, 2026 | Gilde Healthcare Holding B.V. 10% owner | Open-market sale | −20,034 | $22.73 | $455,373 |
| Jul 30, 2026 | Gilde Healthcare Holding B.V. 10% owner | Open-market sale | −28,245 | $23.36 | $659,803 |
| Jun 26, 2026 | Casey M. Tansey Director, 10% owner | Grant or award | +5,046 | — | — |
| Jun 26, 2026 | Kevin K. Sidow Director | Grant or award | +5,046 | — | — |
| Jun 26, 2026 | Andrew Hykes Director | Grant or award | +5,046 | — | — |
| Jun 26, 2026 | Paul Buckman Director | Grant or award | +5,046 | — | — |
| Jun 26, 2026 | Richard Buchholz Director | Grant or award | +5,046 | — | — |
| Jun 15, 2026 | Matthew Fraser Ahearn Director, Officer (Chief Operating Officer) | Open-market sale | −1,644 | $18.20 | $29,921 |
| Jun 15, 2026 | Matthew Fraser Ahearn Director, Officer (Chief Operating Officer) | Open-market sale | −2,500 | $19.26 | $48,150 |
| Jun 12, 2026 | Matthew Fraser Ahearn Director, Officer (Chief Operating Officer) | Open-market sale | −15,856 | $18.68 | $296,190 |
| Apr 30, 2026 | Robert Joseph Ball Director, Officer (CEO & Executive Chairman) | Option exercise | +10,000 | $2.48 | $24,800 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.